Establishment of an immunoassay system for monocyte chemotacticand activating factor (MCAF) and its clinical application
Establishment of an immunoassay system for monocyte chemotacticand activating factor (MCAF) and its clinical application
批准号:
04671430
负责人:
MUKAIDA Naofumi
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The results of the project is summarized as follows.1. We established MCAF-producing cell line by transfecting MCAF cDNA into a mouse myeloma cell line and purified MCAF from the culture supernatants of this cell line. We observed that the preadministration of purified recombinant MCAF could prevent either normal or granulocytopenic mice from lethal infection caused by pseudomonas aeruginosa o r Salmonella typhymurium.2. We established a specific and sensitive ELASA against human MCAF.Using this ELASA, we observed that the pleural fluid levels of MCAF increased in patients with malignant pleurisy upon the administration of an immunomodulator, OK-432. In addition, most human glioblastoma cell lines could produce MCAF in response to IL-1 or TNFalpha, suggesting a potential role of MCAF in tumor immunity.3. We also examined the role of MCAF-related molecule, interleukin-8 (IL-8) in the acute inflammation by administering a neutralizing antibody against IL-8. these experiments demonstrated that IL-8 plays an essential role in neutrophil infiltration and neutrophi-dependent tissue injuries in lipopolysaccharide-induced dermatitis and lung reperfusion injury.4. The determination of urinary IL-8 lavels using ELISA revealed that urinary IL-8 levels increased in the urines of patients with urinary tract infections and those with several types of glomerulonephritis such as lupus nephritis, acute glomerulonephritis, and IgA nephropathy with acute exacerbations.These results imply that the determination of urinary IL-8 level can be used for diagnosing and monitoring several diseases in urinary tracts.In addition, we explored the molecular biological aspects of IL-8 gene activation and established that NF_<-k>B site was essentially involved in the transcription of IL-8 gene in every cell line that we examined.
期刊论文(56)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yasumoto, K., Okamoto, S.-i, Mukaida, N., Murakami, S., Mai, M., Matsushima, K.: "Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a humangastric cancer cell line through acting concurrently on AP-1 and N
Yasumoto, K.、Okamoto, S.-i、Mukaida, N.、Murakami, S.、Mai, M.、Matsushima, K.:“肿瘤坏死因子 α 和干扰素 γ 协同诱导人胃癌细胞中白细胞介素 8 的产生
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ko,Y.-C.,Mukaida,N.,Ishiyama,S.,et al.: "Elevated IL-8 level in the urine of patients with urinary tract infections." Infection and Immunity. 61. 1307-1314 (1993)
Ko,Y.-C.、Mukaida,N.、Ishiyama,S. 等人:“尿路感染患者尿液中 IL-8 水平升高。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Morita, M., Kasahara, T., Mukaida, N., Matsushima, K., Nagashima, T., Nishizawa, M., and Yoshida, M.: "Induction and regulation of IL-8 and MCAF production in human brain tumor cell lines and brain tumor tissues" European Cytokine Network. 4. 351-358 (199
Morita, M.、Kasahara, T.、Mukaida, N.、Matsushima, K.、Nagashima, T.、Nishizawa, M. 和 Yoshida, M.:“人脑中 IL-8 和 MCAF 产生的诱导和调节
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nakano,Y.,Kasahara,T.,Mukaida,N.,et al.: "Prevention of fatal bacterial infection in mice by monocyte chemotactic and activating factor(MCAF)." Infection and Immunity. (印刷中).
Nakano, Y.、Kasahara, T.、Mukaida, N. 等人:“通过单核细胞趋化和激活因子 (MCAF) 预防小鼠致命细菌感染”(正在出版)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Elucidation of the roles of tumor necrosis factor and chemokines in inflammation-associated carcinogenesis
-
批准号:21390117
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2009
-
负责人:MUKAIDA Naofumi
-
依托单位:
Elucidation of the roles of tumor necrosis factor and chemokines in inflammation-associated carcinogenesis
-
批准号:19390112
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.73万
-
财政年份:2007
-
负责人:MUKAIDA Naofumi
-
依托单位:
Identification of a novel tumor marker(s), based on the comprehensive analysis of genes expressed selectively in micometastais site.
-
批准号:16390163
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.41万
-
财政年份:2004
-
负责人:MUKAIDA Naofumi
-
依托单位:
Development of a novel diagnostic method for early detection of chronic liver diseases through the molecular pathological analysis of chronic liver disease models
-
批准号:11470516
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:1999
-
负责人:MUKAIDA Naofumi
-
依托单位:
Pathophyiological and immunopharmacological studies on chemokines and their receptors
-
批准号:10044254
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$5.44万
-
财政年份:1998
-
负责人:MUKAIDA Naofumi
-
依托单位:
Development of assay systems for chemokines and their receptors and establishment of their diagnostic value
-
批准号:10557249
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.13万
-
财政年份:1998
-
负责人:MUKAIDA Naofumi
-
依托单位:
Molecular biological analysis of mechanisms of interleukin-8 production, with a refernce to the roles of reactive oxygen
-
批准号:06670346
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:MUKAIDA Naofumi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
-
批准号:32371150
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:井淼
-
依托单位:
SDF-1/CXCR4信号通路在NMO-IgG介导的炎性脱髓鞘视神经炎中促进髓鞘修复的作用及机制研究
-
批准号:81900849
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:康皓
-
依托单位:
Chemokine-Gli2信号环路调控肝癌生长的分子机制及其靶点价值
-
批准号:81660467
-
项目类别:地区科学基金项目
-
资助金额:39.0万元
-
批准年份:2016
-
负责人:石超
-
依托单位:
间充质干细胞对异基因T细胞体内趋化影响机制的研究
-
批准号:81070448
-
项目类别:面上项目
-
资助金额:34.0万元
-
批准年份:2010
-
负责人:任汉云
-
依托单位:
趋化因子及其受体介导的血源性干/祖细胞及血管内皮细胞在新生血管性眼病中免疫病理机制及干预
-
批准号:30972712
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2009
-
负责人:陆培荣
-
依托单位:
趋化因子及其受体与新生血管性眼病的形成机制及干预研究
-
批准号:30771978
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2007
-
负责人:陆培荣
-
依托单位:
趋化因子及其受体与肝癌的发生发展
-
批准号:30572120
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2005
-
负责人:陆培荣
-
依托单位:
CKLF1在哮喘气道上皮损伤及重塑中的作用
-
批准号:30370622
-
项目类别:面上项目
-
资助金额:19.0万元
-
批准年份:2003
-
负责人:谭亚夏
-
依托单位: